<DOC>
	<DOCNO>NCT01739673</DOCNO>
	<brief_summary>This study evaluate efficacy ultraviolet-A ( UVA ) riboflavin application ( also often referred corneal collagen crosslinking ) method enhance treatment infectious keratitis .</brief_summary>
	<brief_title>Ultraviolet-A Riboflavin Treatment Infectious Keratitis</brief_title>
	<detailed_description />
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Keratitis</mesh_term>
	<mesh_term>Riboflavin</mesh_term>
	<criteria>1 . Subjects must 18 year age old . 2 . Ability provide write informed consent . 3 . Likely complete study visit . 4 . Subjects must one eye diagnosis infectious keratitis . 1 . A corneal perforation . 2 . Descemetocele . 3 . Pregnancy breastfeed . 4 . Active Herpes corneal disease . 5 . Patient unwilling unable comply medication regimen follow appointment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Infectious Keratitis</keyword>
</DOC>